Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SAMUEL E GANDY

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1588684682
CMS profile
253104
Location
NEW YORK, NY

General Payments · PY2023–2024

$13,853.41

  • Reported across 25 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$6,265.14

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $4,777.50 2
Travel and Lodging $1,057.48 6
Food and Beverage $430.16 9

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $2,437.50 1
EISAI INC. $2,340.00 1
Alnylam Pharmaceuticals Inc. $1,362.64 14
Lilly USA, LLC $125.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2023 $7,588.27 8
PY2024 $6,265.14 17

Payment records · PY2024 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alnylam Pharmaceuticals Inc. $561.58 04/12/2024 Travel and Lodging Undisputed 01/23/2026 1125843757 CMS
Alnylam Pharmaceuticals Inc. $219.00 05/09/2024 Travel and Lodging Undisputed 01/23/2026 1125843755 CMS
Alnylam Pharmaceuticals Inc. $100.62 05/09/2024 Travel and Lodging Undisputed 01/23/2026 1125843759 CMS
Alnylam Pharmaceuticals Inc. $24.24 05/09/2024 Food and Beverage Undisputed 01/23/2026 1125843761 CMS
Alnylam Pharmaceuticals Inc. $35.00 05/09/2024 Food and Beverage Undisputed 01/23/2026 1125843763 CMS
Alnylam Pharmaceuticals Inc. $130.91 05/09/2024 Food and Beverage Undisputed 01/23/2026 1125843765 CMS
Alnylam Pharmaceuticals Inc. $48.50 05/09/2024 Food and Beverage Undisputed 01/23/2026 1125843767 CMS
Alnylam Pharmaceuticals Inc. $24.24 05/09/2024 Food and Beverage Undisputed 01/23/2026 1125843773 CMS
Alnylam Pharmaceuticals Inc. $100.62 05/09/2024 Travel and Lodging Undisputed 01/23/2026 1125843775 CMS
Alnylam Pharmaceuticals Inc. $20.92 05/09/2024 Travel and Lodging Undisputed 01/23/2026 1125843811 CMS
Alnylam Pharmaceuticals Inc. $54.74 05/09/2024 Travel and Lodging Undisputed 01/23/2026 1125843813 CMS
Alnylam Pharmaceuticals Inc. $7.60 05/10/2024 Food and Beverage Undisputed 01/23/2026 1125843805 CMS
Alnylam Pharmaceuticals Inc. $19.62 05/10/2024 Food and Beverage Undisputed 01/23/2026 1125843807 CMS
Alnylam Pharmaceuticals Inc. $15.05 05/10/2024 Food and Beverage Undisputed 01/23/2026 1125843809 CMS
Eisai Inc. $2,340.00 01/19/2024 Consulting Fee Undisputed 01/23/2026 1110779375 CMS
Lilly USA, LLC $125.00 10/10/2024 Food and Beverage Undisputed 01/23/2026 1135403430 CMS
Novo Nordisk Inc $2,437.50 04/10/2024 Consulting Fee Undisputed 01/23/2026 1096937443 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2023, 2024
Source files
Dataset page · Bulk file · PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.